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O'Connor: When the Eyes Fail

When the Eyes Fail
By Julie O’Connor

“I’m so sorry, Mrs. Smith. Your son’s loss of night vision and decreased peripheral vision is
caused by an inherited genetic eye disease that affects the retina called retinitis pigmentosa or RP.
RP causes the degeneration of photoreceptor cells in the retina. It is programmed into his cells,
and is not caused by injury or infection. Genetic mutations essentially send faulty messages to the
retinal cells which lead to their progressive degeneration. Eventually this leads to vision loss and
most diagnosed with RP are legally blind by age 40. Some studies suggest that treatment with
Vitamin A may slow the progression of this disease, and current research shows some promising
strides for future treatments, but currently there is no effective treatment for recovery of visual
loss from RP as of today.”
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Using a harmless virus, they introduced a gene
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called channelrhodopsin-2 (ChR2), into surviving
inner retinal neurons in mice that were genetically
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